Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Biological and Psychological Profiles of Hospital Healthcare Professionals During a Stressful Wartime.

Journal of general internal medicine·2026
Same author

Food Insecurity Is Associated with Increased Risk of Ischemic Stroke.

American journal of preventive medicine·2026
Same author

Trends in the Incidence of Early- and Late-Onset Dementia in 2011-2019: A Nationwide Population-Based Study.

Dementia and geriatric cognitive disorders·2026
Same author

Differential Association Between Surrounding Greenness and Mortality in Individuals With Coronary Heart Disease.

JACC. Advances·2026
Same author

Workability and Biological Biomarkers of Hospital Professionals during War.

QJM : monthly journal of the Association of Physicians·2026
Same author

The association between Post-COVID syndrome and self-stigma among the adult Israeli population during the COVID-19 pandemic.

BMC public health·2026

Related Experiment Video

Updated: May 15, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy.

Arnon Blum1, Dorina Socea, Rotem Shelly Ben-Shushan

  • 1Department of Medicine, Baruch-Padeh Medical Center, Poriya15208, Israel. navablum@hotmail.com

European Cytokine Network
|January 19, 2013
PubMed
Summary
This summary is machine-generated.

Inflammatory and angiogenic markers like hs-CRP and sVCAM-1 were elevated in early diabetic retinopathy stages but decreased in proliferative stages. These markers may help predict diabetic vascular disease progression and guide interventions.

More Related Videos

Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Related Experiment Videos

Last Updated: May 15, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Diabetic retinopathy (DR) is a severe complication of diabetes mellitus (DM), linked to microvascular damage and increased cardiovascular risk.
  • The progression of DR stages is associated with distinct pathophysiological changes.

Purpose of the Study:

  • To investigate if inflammatory and angiogenic markers can differentiate stages of type 2 diabetes with diabetic retinopathy.
  • To determine if these markers predict the development of microvascular damage.

Main Methods:

  • Seventy-three type 2 diabetic patients were categorized into three groups based on DR severity: no retinopathy, non-proliferative retinopathy, and proliferative retinopathy.
  • Twenty-three healthy subjects served as controls.
  • Levels of high-sensitivity C-reactive protein (hs-CRP), soluble vascular cell adhesion molecule 1 (sVCAM-1), and vascular endothelial growth factor (VEGF) were measured.

Main Results:

  • Patients with no or non-proliferative retinopathy showed significantly higher hs-CRP and sVCAM-1 levels compared to controls.
  • VEGF levels were not significantly different in early stages but decreased significantly in proliferative retinopathy.
  • Diabetes duration and HbA1c levels varied between early stages but not between non-proliferative and proliferative stages.

Conclusions:

  • Elevated inflammatory and angiogenic markers (hs-CRP, sVCAM-1) are present in early stages of diabetic retinopathy.
  • A decrease in VEGF levels correlates with the progression to proliferative diabetic retinopathy.
  • These biomarkers may aid in detecting diabetic vascular disease progression and informing early interventions to prevent systemic complications.